Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-071457
Filing Date
2024-08-21
Accepted
2024-08-21 16:13:41
Documents
7
Period of Report
2024-08-21

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0211994-6k_mdx.htm 6-K 14083
2 AMENDMENT TO THE CREDIT AGREEMENT BY AND AMONG MDXHEALTH, INC., THE GUARANTORS P ea021199401ex4-1_mdx.htm EX-4.1 31288
3 SECOND AMENDMENT TO THE CREDIT AGREEMENT BY AND AMONG MDXHEALTH, INC., THE GUARA ea021199401ex4-2_mdx.htm EX-4.2 42620
4 2024 INTERIM REPORT ea021199401ex99-1_mdx.htm EX-99.1 338108
5 PRESS RELEASE, DATED AUGUST 21, 2024 ea021199401ex99-2_mdx.htm EX-99.2 89690
6 GRAPHIC ex99-1_001.jpg GRAPHIC 1920
7 GRAPHIC ex99-2_001.jpg GRAPHIC 1920
  Complete submission text file 0001213900-24-071457.txt   522531
Mailing Address CAP BUSINESS CENTER RUE D'ABHOOZ, 31, B-4040 HERSTAL C9 00000
Business Address CAP BUSINESS CENTER RUE D'ABHOOZ, 31, B-4040 HERSTAL C9 00000 949-271-9221
MDxHealth SA (Filer) CIK: 0001872529 (see all company filings)

EIN.: 000000000 | State of Incorp.: C9
Type: 6-K | Act: 34 | File No.: 001-40996 | Film No.: 241228873
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)